Aquatic Capital Management LLC

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1803916 CHICAGO, IL

Position in XENE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,605,421

+$4,252,777 QoQ

Shares Held

79,199

+653.5% QoQ

Ownership

0.082%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Aquatic Capital Management LLC holds $123,092,373 across 91 Biotechnology names. XENE ranks #7 (3.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	147,379	$11,066,689
2	ALNY	Alnylam Pharmaceuticals, Inc.	31,061	$10,277,153
3	EXEL	Exelixis, Inc.	194,571	$8,345,150
4	RPRX	Royalty Pharma plc	127,227	$6,103,079
5	ARWR	Arrowhead Pharmaceuticals, Inc.	80,227	$5,030,232
6	CYTK	Cytokinetics Inc	72,478	$4,777,024
7	XENE	Xenon Pharmaceuticals Inc. This page	79,199	$4,605,421
8	NKTR	Nektar Therapeutics	57,014	$4,102,157

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,605,421	79,199	+653.5%	Shares	Sole	2026-05-15
2025-03-31	$352,644	10,511	+27.3%	Shares	Sole	2025-05-15
2024-12-31	$323,792	8,260	+96.7%	Shares	Sole	2025-02-14
2024-06-30	$163,758	4,200	-83.0%	Shares	Sole	2024-08-14
2024-03-31	$1,063,335	24,700	+26.7%	Shares	Sole	2024-05-15
2023-12-31	$898,170	19,500	+27.5%	Shares	Sole	2024-02-14
2023-09-30	$522,648	15,300	+665.0%	Shares	Sole	2023-11-14
2023-03-31	$71,580	2,000	+400.0%	Shares	Sole	2023-05-15
2022-03-31	$12,228	400	-92.6%	Shares	Sole	2022-05-16
2021-12-31	$168,696	5,400	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.